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ABSTRACT 1	  
Recent insights into bacterial biofilm matrix structures have induced a paradigm shift 2	  
towards the recognition of amyloid fibers as common building block structures that 3	  
confer stability to the exopolysaccharidic matrix. Herein, we describe the functional 4	  
amyloid systems related with biofilm matrix formation in both gram-negative and gram-5	  
positive bacteria and recent knowledge regarding the interaction of amyloids with other 6	  
biofilm matrix components like eDNA and the host immune system. In addition, we 7	  
summarize the efforts to identify compounds that target amyloid fibers for therapeutic 8	  
purposes and recent developments that take advantage of the amyloid structure to 9	  
engineer amyloid fibers of bacterial biofilm matrices for biotechnological applications.  10	  
 11	  
  12	  
	   3 
Amyloid structures have been traditionally associated with several incurable 1	  
degenerative human diseases including Alzheimer’s, Parkinson’s, Huntington’s and 2	  
prion diseases (1). In these cases, amyloid fibers formation occurs upon aberrant 3	  
misfolding of soluble and functional proteins (2). However, numerous evidences 4	  
indicate that amyloid fibers are not just the result of aberrant protein folding, but they 5	  
are produced on purpose in different non-pathological conditions to provide organisms 6	  
with beneficial properties (3). The microbial world make use of this type of protein 7	  
folding for a number of processes relevant for bacterial growth and survival in the 8	  
environment, such as morphological differentiation of filamentous bacteria (4, 5)), 9	  
adhesion to host tissues (6), detoxification of toxic compounds (7-9), electron transport 10	  
(10), and structural scaffolds in biofilm matrices (1).  11	  
Amyloid structure is an attractive building material because it is generally resistant to 12	  
harsh denaturing conditions and in most cases cannot be degraded by proteases (1, 11). 13	  
In addition, polymerization of amyloid proteins is metabolically cheap because it occurs 14	  
in the absence of energy. Thus, the amyloid conformation is suitable as a component of 15	  
the extracellular matrix where the energy sources are limited (12).  16	  
The aim of this review is to describe the current knowledge on functional bacterial 17	  
amyloids involved in building biofilm matrix complexes and highlight the differences 18	  
on the composition and assembly machineries. Additionally, we will also discuss 19	  
recently discovered compounds able to destabilize bacterial biofilms through their 20	  
action on amyloids, and the use of such proteinaceous nanostructures as tools to 21	  
promote functional biofilms with biotechnological purposes.  22	  
 23	  
Amyloid structures with dedicated fiber assembly machinery 24	  
The most studied and characterized bacterial amyloid system is curli fimbriae in 25	  
	   4 
Escherichia coli. Curli fimbriae show the prototypical biophysical properties of amyloid 1	  
fibers: ordered  β-sheet-rich fibers, resistant to proteases and able to bind amyloid 2	  
specific dyes (Congo red, Thioflavin-T). Curli assembly requires the products of at least 3	  
two divergently transcribed operons, csgBAC and csgDEFG (13). CsgA and CsgB are 4	  
the protein subunits that make up curli, whereas the rest of the proteins are involved in 5	  
the regulation of the production, stabilization and secretion of CsgA and CsgB subunits 6	  
(Figure 1B) (1, 14-16). CsgA has the propensity to self-aggregate, however it requires 7	  
the CsgB subunit for nucleation into fibers (14, 17). CsgA and CsgB are translocated 8	  
into the periplasm by the Sec translocon system and exported to the extracellular media 9	  
through a pore-like structure constituted by the CsgG protein formed in the outer 10	  
membrane (18). Associated with this pore are the CsgC, CsgE and CsgF proteins, that 11	  
modulate subunit stability and proper assembly of curli fibers (18, 19). CsgD is the 12	  
master regulator that controls at transcriptional level the expression of csgBAC operon 13	  
and also adrA, involved in post-transcriptional regulation of cellulose synthesis, which 14	  
is another common component of the biofilm matrix (20-23). CsgD activity is also 15	  
controlled by a variety of regulatory systems that respond to environmental signals 16	  
including osmolarity, pH, temperature and nutrient availability (24, 25). Curli fibers 17	  
mediate bacterial adhesion to a variety of host proteins or abiotic surfaces promoting 18	  
biofilm formation and pathogenicity (26-31).  19	  
Production of curli fibers have been described in Salmonella, Citrobacter and 20	  
Enterobacter (32), but genes with homology to proteins coding for the curli system are 21	  
found in members of Proteobacteria, Bacteroidetes, Firmicutes and 22	  
Thermodesulfobacteria (33) suggesting that the formation of curli fibers is a common 23	  
strategy to provide structural integrity to the biofilm matrix (15). 24	  
An example of extracellular fibers with structural and functional similarity to curli 25	  
	   5 
fimbriae of E. coli has been described in various species of Pseudomonas including P. 1	  
aeruginosa, P. fluorescens, and P. putida (34). In this case, the protein components for 2	  
amyloid assembly are encoded in the fapA-F operon (35). Biophysical analysis of 3	  
purified Fap fimbria showed the presence of extensive β-sheet structure, as well as 4	  
binding to the specific Thioflavin-T dye (35). Biochemical analysis of fibrils 5	  
composition identified FapC protein as the major protein component, although small 6	  
amounts of FapB and FapE were also present (35). As for CsgB in curli system, FapB 7	  
would act as a fibrillation nucleator of FapC (Figure 1B). Fap amyloid fibers facilitate 8	  
attachment to the abiotic surfaces, and also provide strength to the mature biofilm 9	  
matrix structure, for instance, in the plant rizosphere (34). Fap fibrils have been shown 10	  
to bind extracellular metabolites within the biofilm, such as quorum sensing molecules 11	  
and redox mediators, modulating their release and retention when required. This implies 12	  
a potential new role for functional amyloids in molecular retention and indirect 13	  
mediation of cell function (36). Again, genes encoding for proteins with homology to 14	  
the Fap systems are present within species belonging to the Beta-, Gamma- and 15	  
Deltaproteobacteria (37). 16	  
Functional fibers with amyloidogenic properties have been shown to be part of the 17	  
extracellular matrix of biofilms formed by the soil bacteria Bacillus subtilis and B. 18	  
cereus. In this case, the biofilm matrix contains TasA made amyloid-like fibers that 19	  
hold cells together and provide structural support for biofilm maintenance (38, 39). 20	  
TasA is expressed from the tapA-sipW-tasA operon, together with two protein, TapA 21	  
and SipW, on which depend the formation of the fibrils. The sipW gene encodes a type I 22	  
signal peptidase that is specifically required for the processing and secretion of TasA 23	  
and TapA (38), whereas TapA is an accessory protein that promotes the efficient 24	  
polymerization of TasA subunits at the cell envelope (Figure 1A) (9, 40, 41). As well as 25	  
	   6 
for curli, the formation of TasA amyloid fibers is a highly regulated mechanism that 1	  
involves the participation of a master regulator, SinR, which directly represses the 2	  
expression of tapA-sipW-tasA operon and the biosynthesis of an exopolysaccharide EPS 3	  
(42). Under conditions favorable for biofilm development, SinI antagonizes the 4	  
repressive activity of SinR, leading to matrix formation (38). A further level of control 5	  
of amyloid assembly in B. subtilis might be given by the bifunctional signal peptidase, 6	  
SipW. Disruption of the peptidase active-site prevented the processing of TasA but did 7	  
not affect biofilm formation capacity, while deletion of the carboxy-terminal region of 8	  
SipW affected the expression of the repressor SinR, thus impairing the induction of 9	  
biofilm matrix genes (43).  10	  
A special example of extracellular fibers formed by the polymerization of a monomer 11	  
that it is secreted by a dedicated secretion apparatus corresponds to the phenol soluble 12	  
modulins (PSMs) in Staphylococcus aureus (44). PSMs can be classified according to 13	  
their length in α-PMSs (20–25 amino acids), and β-PSMs (43–45 amino acids). S. 14	  
aureus expresses four α-PSM peptides encoded in the αpms locus, two β-PSM peptides 15	  
encoded in the βpsm locus, and the δ-toxin encoded within RNAIII, the effector 16	  
molecule of the Agr system {Cheung:2014cz}. These peptides are exported by an ATP-17	  
binding cassette (ABC) transporter with two separate membrane components (PmtB and 18	  
PmtD) and two separate ATPases (PmtA and PmtC) (45). Interestingly, PSM 19	  
expression is directly regulated by binding of the AgrA response regulator to psm loci 20	  
instead of the effector molecule RNAIII of accessory gene regulator system (Agr) (46). 21	  
At the extracellular media PSMs can be present either as soluble peptides or as 22	  
polymerized amyloid structures. When soluble, PSMs form an amphipathic α-helix with 23	  
surfactant-like properties that promote biofilm disassembly (44, 47). Under still poorly 24	  
understood environmental conditions, the soluble α-helical peptides switch to β-sheet 25	  
	   7 
rich protein aggregates and in this state, they provide functional support to the biofilm 1	  
community (Figure 1A) (48). Thus, PSMs are bifunctional proteins that may be stored 2	  
as inert fibrils in a sessile biofilm until conditions arise that favor their dissociation to 3	  
promote biofilm disassembly and virulence (44). Recent evidences suggest that PSMs 4	  
aggregation can be accelerated by the presence of trace amounts of AgrD, the signal 5	  
peptide of the S. aureus quorum-sensing system, since AgrD would self-aggregate and 6	  
act as seeds, allowing the incorporation of PSMs into the growing aggregate (49).  7	  
 8	  
Surface associated proteins with amyloidogenic properties 9	  
Amyloid assembly mechanisms like the ones described above represent sophisticated 10	  
machineries that strictly control the polymerization of protein subunits into amyloid 11	  
fibers outside the cell. This is achieved by the expression of accessory genes generally 12	  
organized within an operon, each of which codifies for a protein with a specific function 13	  
in amyloid assembly machinery. However, less complex models of auto-aggregative 14	  
cell-surface proteins with amyloid properties have been also studied in different 15	  
bacterial genera.  16	  
The Bap case is the most recent example of a surface protein with amyloid behavior 17	  
involved in biofilm development. Bap is a high molecular weight protein present in 18	  
many staphylococci that is covalently anchored to the peptidoglycan through a sortase-19	  
dependent reaction recognizing the LPXTG motif (50, 51). Bap is a multidomain 20	  
protein structurally organized into four domains. Region A contains two short repeats of 21	  
32 amino acids. Region B contains two EF-hand motifs that regulate Bap functionality 22	  
upon binding to calcium (52). Region C consists of a series of identical repeats of 86 23	  
amino acids, followed by a C-terminal region D containing serine-aspartate rich 24	  
repeated sequence. Because Bap is covalently linked to the cell wall, it was believed 25	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that Bap mediated intercellular adhesion through homophilic interactions between 1	  
opposing proteins in neighboring cells as it has been shown for SasG protein (53-58). 2	  
However, recent results indicate that Bap behaves in a completely different manner. 3	  
After secretion, Bap is proteolytically processed and the N-terminal region released 4	  
(amino acids 49 to 819) (Figure 1C) (Taglialegna et al; Plos Pathogens under revision). 5	  
The resulting N-terminal fragments adopt a molten globule-like conformation that 6	  
proceeds to a β-sheet rich form that self-assemble into amyloid-like aggregates when 7	  
the pH becomes acidic and calcium concentration is below 1mM. At higher calcium 8	  
concentrations, binding of the cation to the EF-hand domains of region B stabilizes the 9	  
molten globule-like state hindering the proper self-assembly of the N-terminal region. 10	  
These findings define a dual function for Bap, first as a sensor and then as a scaffold 11	  
protein that promotes biofilm development under specific environmental conditions. 12	  
This mechanism is substantially different to the curli amyloid assembly machinery for 13	  
several reasons: i) Bap secretion does not require a dedicated secretion machinery 14	  
because it is efficiently exported when S. aureus Newman bap-negative strain is 15	  
complemented with the bap gene (59); ii) Bap does not require a chaperon to prevent 16	  
toxic premature assembly inside the cytoplasm since Bap is assembled extracellularly 17	  
after protein processing; iii) Bap expression does not require a tightly transcriptional 18	  
regulation since amyloid formation depends not only on the presence of enough amount 19	  
of Bap but on specific environmental conditions (Taglialegna et al; Plos Pathogens 20	  
under revision). 21	  
Bap is present in coagulase-negative staphylococci and many other bacteria use Bap-22	  
like proteins to build a biofilm matrix suggesting that the amyloid-like aggregation 23	  
described for Bap may be widespread among pathogenic bacteria (51, 59)(Taglialegna 24	  
et al; Plos Pathogens under revision). 25	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Another example of a surface associated protein with amyloidogenic properties is 1	  
adhesin P1 (also called antigen I/II) from the cariogenic pathogen Streptococcus mutans 2	  
(60). This protein is found covalently liked to the peptidoglycan and also in the culture 3	  
media (60). The crystal structure of P1 shows that the protein has a highly extended 4	  
fibrillar structure in which an alanine-rich repeat region intertwine through an α-helix 5	  
with the non-contiguous type II helix adopted by the proline-rich repeats region (61). P1 6	  
also contains two globular domains, V-region and C-terminus, that assemble into β-7	  
sheet–rich fibers characteristics of amyloid fold (Figure 1C) (60, 62, 63).  8	  
The α-module of Ag43 autotransporter of E. coli constitutes another example of a 9	  
surface protein with amyloid propensity. Ag43 is composed of two domains: the β-10	  
domain, which forms an outer membrane integrated pore and the α-domain, which is 11	  
secreted to the extracellular environment through the folded β-domain after processing 12	  
of the Ag43 preprotein. The α and β-domains remain in contact via non covalent 13	  
interactions (64). Ag43α promotes bacterial auto-aggregation and biofilm formation and 14	  
it adopts a parallel right-handed β-helix conformation that resemble the amyloid 15	  
structure established for curli (Figure 1D) (65, 66). However, this structure cannot be 16	  
considered a typical amyloid fibril because the protein remains anchored to the cell 17	  
surface and it is unable to polymerize into fibers. Besides, it was described that pairs of 18	  
α domains mediate interaction between different cells through a “Velcro-like” 19	  
mechanism in which the formation of α-homodimers organized in a head-to-tail 20	  
conformation and stabilized by hydrogen bonds and electrostatic interactions, result in 21	  
the aggregation of cells (64). 22	  
 23	  
Role of biofilm associated extracellular DNA in amyloid polymerization 24	  
When studying the role of functional amyloids in the building of an extracellular 25	  
	   10 
bacterial matrix, the often-made question is what actually assists or triggers the 1	  
assembly of monomeric proteins into fibers, a reaction that is thermodynamically 2	  
unfavorable and constitutes the rate-limiting step of the reaction (67).  3	  
The possibilities to overcome this kinetic limitation range from the presence of trace 4	  
amounts of preformed aggregates of the same or heterologous protein, binding to other 5	  
elements present in the cell-envelope or the presence of amyloid prone-to-aggregate 6	  
stretches into the amino acidic sequence of the protein. As described previously, CsgB, 7	  
FapB, TapA and AgrD act as fibrillation nucleators. Some recent information pointed 8	  
out that DNA might also play this role. Direct interaction of DNA with two major 9	  
bacterial amyloids, curli and PSMs, reveals its role as nucleator of amyloid 10	  
polymerization (68). In the case of curli fibers, Gallo et al. (68) showed that Salmonella 11	  
curli fibers bind tightly to extracellular DNA (eDNA) protecting it from the degradation 12	  
by DNAses. Furthermore, addition of three different types of nucleic acids (synthetic 13	  
oligonucleotide, Salmonella genomic DNA or eukaryotic DNA) indistinctly reduced the 14	  
lag phase for curli fibers polymerization, suggesting a mechanism by which DNA 15	  
molecules trigger the assembly of CsgA monomers into highly stable complexes that 16	  
would provide stability to S. typhimurium biofilms (68). 17	  
The presence of eDNA seems to play a key role also in the formation of amyloid fibers 18	  
in S. aureus biofilms. In a recent report, Schwartz et al. (69) showed that biofilms 19	  
formed by S. aureus mutant strains, which do not contain eDNA in the extracellular 20	  
matrix, failed to assemble PSMs amyloid fibrils, even when the monomeric amyloid-21	  
like subunits were present (69). Further analysis revealed that DNA was able to promote 22	  
the polymerization of purified PSMα1 at concentrations in which this peptide is not 23	  
able to self-polymerize suggesting that DNA increases the peptide concentration above 24	  
the threshold needed to start fibers assembly by attracting the positively charged PSMs 25	  
	   11 
(69).  1	  
Further characterization of the interactions between amyloid fibers and extracellular 2	  
DNA is necessary to understand how DNA triggers amyloid fibers assembly and how 3	  
the interaction between these two structures protects the DNA from degradation by 4	  
DNAses. By extending our current knowledge on the polymerization process and the 5	  
factors that governs it, the design of molecules or strategies aimed at disrupt amyloid 6	  
assemblages appears as a wonderful biotechnological tool to fight against biofilms. 7	  
Examples of first attempts in this direction are provided in further section. 8	  
 9	  
Functional amyloids in microbiome-host interactions. 10	  
As a result of life-long commensal permanence of bacteria within the human body, it 11	  
must be considered that microbial-generated amyloids, together with other related 12	  
microbial secretory products, could be potential contributors of the pathology of 13	  
progressive immunological and neurological disorders some of them associated with 14	  
amyloidogenesis (70). Curli fibers are able to stimulate the innate immune system by 15	  
recognizing the Toll-like receptor (TLR) 2-TLR1 heterocomplex (71-73). Interestingly, 16	  
a very recent study highlights the role of curli-DNA complexes in the stimulation of the 17	  
innate and adaptive immune system and suggests that this complexes can accelerate 18	  
autoimmunity contributing to Systemic Lupus Erythematosus pathogenesis (68). In an 19	  
indirect manner, the strong innate immune response activated by bacterial amyloids 20	  
could stimulate neuropathogenic signals that promote amyloid aggregation and 21	  
inflammatory degeneration characteristic of age-related neurological diseases such as 22	  
Alzheimer. Bacterial amyloids leakage through compromised gastrointestinal tract or 23	  
blood-brain barriers could also directly contribute to progressive neuroamyloidogenesis 24	  
(70). These data provide evidences of how biofilm-forming bacteria can contribute to 25	  
	   12 
the progression of some immunological and neurological diseases and point amyloid 1	  
components as potential molecular target for their treatment.  2	  
On the other hand, owing to their immunomodulatory activity, bacterial amyloids have 3	  
been proposed as potential therapeutic candidates to treat intestinal inflammatory 4	  
disorders as recently shown by Oppong et al. (74). TLR2 activation by curli fibrils from 5	  
both commensal and pathogenic microbiota resulted in the production of an 6	  
immunomodulatory cytokine of intestinal homeostasis that ameliorated inflammation in 7	  
a mouse model of colitis (74). However, further studies are needed to probe the 8	  
immunomodulatory function of bacterial amyloids and their use as therapeutic 9	  
candidates to treat chronic inflammatory disorders. 10	  
 11	  
Amyloids as targets to fight against biofilms 12	  
Because biofilms can cause devastating consequences in clinical and industrial settings 13	  
there has been an increasing interest to develop biofilm control strategies. The apparent 14	  
ubiquity of amyloid fibers in biofilm matrices has led to the screening of molecules that 15	  
might interrupt its production or assembly.  16	  
The first molecule to show inhibitory properties against biofilm amyloid fibrils was the 17	  
ring-fused 2-pyridone called FN075, which is an analogue of BipC10 pilicide 18	  
compound. FN075 proved to significantly reduce the polymerization of the main curli 19	  
subunit CsgA and the biogenesis of curli and type 1 pili in uropathogenic E. coli  (75). 20	  
This double curlicide-pilicide property of FN075 is important from a therapeutic point 21	  
of view because E. coli can use both structures, pili or curli, to promote surface 22	  
attachment and subsequent biofilm formation (75). Authors further tested FN075 in a 23	  
mouse urinary tract infection model to evaluate inhibitory activity in vivo. Pretreatment 24	  
with FN075 of uropathogenic E. coli grown under pili-forming but not curli-forming 25	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conditions, significantly attenuated virulence demonstrating the importance of inhibit 1	  
pili formation to decrease infection (75). However, direct treatment of the mice with the 2	  
inhibitor to validate its protective role in vivo remains to be done. 3	  
Romero and collaborators (76) used a simple screening method based on the alteration 4	  
of B. subtilis wrinkly biofilm phenotype to search for possible anti-biofilm compounds. 5	  
They successfully identified that AA-861, a benzoquinone derivative with anti-6	  
inflammatory activity and parthenolide, a sesquiterpene lactone with anti-inflammatory 7	  
and anti-cancer activities, inhibited TasA polymerization into amyloid-like fibers in 8	  
vitro (76). Interestingly, AA-861 was more efficient to inhibit TasA polymeritization 9	  
whereas parthenolide was more potent destroying pre-formed biofilms in vivo indicating 10	  
that these molecules can work additively to inhibit biofilm formation (76). Because 11	  
these two compounds showed anti-biofilm activity against E. coli and B. cereus, and 12	  
also impeded the conversion of the yeast New1 protein to its prion state, they seem to 13	  
have activity against proteins of different origins (76). 14	  
Within the field of amyloid fibers and the possible ways to avoid their polymerization, 15	  
is important to emphasize all the efforts made in fighting against human amyloidogenic 16	  
degenerative diseases. Several small polyphenol molecules have been demonstrated to 17	  
remarkably inhibit the formation of fibrillar assemblies in vitro and their associated 18	  
cytotoxicity, being their mechanism primarily based on antioxidative properties or 19	  
structural constraints (77). The compound (-)-epi-gallocatechine gallate (EGCG), for 20	  
example, inhibits the fibrillogenesis of α-synuclein and amyloid-β, two amyloid 21	  
peptides crucially involved in Alzheimer’s and Parkinson’s diseases respectively, and is 22	  
a potent remodeling agent of mature amyloid fibrils (78, 79). Although, its role against 23	  
human amyloid fibrils remains to be demonstrated, the efficiency of EGCG to inhibit 24	  
Streptococcus mutans and S. aureus biofilms has been shown (60) (Taglialegna et al; 25	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Plos Pathogens under revision). This gives us the clue that compounds able to inhibit 1	  
human aberrant amyloids could be active also against bacterial functional amyloids, and 2	  
vice versa. In this regard, it has been recently reported that the periplasmic protein CsgC 3	  
is highly effective inhibiting human α-synuclein and CsgA amyloid formation, while it 4	  
does not affect polymerization of Aβ42 (80).  5	  
In a recent report, Rifapentine, an antibiotic that targets RNA polymerase and is often 6	  
used to treat tuberculosis, was shown to inhibit curli-dependent biofilm formation on 7	  
different surfaces at a concentration that did not alter bacterial growth (81). Specifically, 8	  
this antibiotic prevented curli operon transcription as shown by reduction of the levels 9	  
of mRNA of each csg gene in the presence of increasing concentrations of rifapentine. 10	  
Moreover, expression of cellulose-related genes (bscA and adrA) that are regulated by 11	  
CsgD were also decreased in the presence of rifapentine (81).  12	  
A mixture of D-amino acids produced by Bacillus subtilis displayed the capacity at 13	  
nanomolar concentration to prevent biofilm formation and disrupt existing biofilms by 14	  
causing the release of TasA amyloids fibers (82). In the same work it was shown that D-15	  
amino acids prevented biofilm formation in S. aureus and P. aeruginosa (82). However, 16	  
the effect of D-aminoacids on inhibition of biofilm development must be considered 17	  
with caution because a recent report was unable to reproduce the inhibitory effect of D-18	  
amino acids on biofilm development of S. aureus and B. subtilis (83).  19	  
Finally, the property of protein aggregation and its cytotoxicity can be used to fight 20	  
against bacterial pathogens during infection (84). Bednarska and collaborators 21	  
developed an ingenious strategy in this regard: they designed peptides encoding 22	  
aggregation-prone sequence stretches of bacterial proteins, some of them with an 23	  
amyloid-like nature, that specifically penetrate bacteria causing aggregation of 24	  
polypeptides in the cytosol, and ultimately leading to bacterial death. The interesting 25	  
	   15 
point is that these peptides had no detectable effects on host cells (85). 1	  
 2	  
Biotechnological applications of biofilm amyloid fibers 3	  
Amyloid fibrils are attractive natural building blocks for the design of new 4	  
nanostructures, nanomaterials and networks of filaments which can be functionalized 5	  
for specific applications in nanotechnology and nanomedicine (86). Several applications 6	  
are being considered for using amyloids as nanowires and nanotubes for electronics, as 7	  
nanosensors, as amyloid-based gels in cell adhesion and wound healing, and as drug 8	  
delivery systems (87). 9	  
Recently, two elegant studies have utilized the properties of bacterial curli fibers to 10	  
engineer cellular consortia and obtain artificial biofilms for biotechnological 11	  
applications. Chen and co-workers (88) developed controllable and autonomous 12	  
patterning of curli fibrils assembled in E. coli cells. The system used external chemical 13	  
inducers to activate synthetic gene circuits that produced engineered CsgA subunits that 14	  
self-assemble in functionalized curli fibrils and biofilms. By combining inducer 15	  
gradients and subunit engineering, this system gives the possibility to fabricate 16	  
multiscale patterning fibers. The proposed system constitutes a versatile scaffold that is 17	  
able to synthesize fluorescent quantum dots, gold nanowires, nanorods and 18	  
nanoparticles, composing switchable conductive biofilms. The other work describes a 19	  
Biofilm-Integrated Nanofiber Display (BIND) system that consists in genetically 20	  
program the E. coli biofilm extracellular matrix by fusing functional peptide domains to 21	  
the CsgA protein. This technique is compatible with a wide range of peptide domains of 22	  
various lengths and secondary structures since they maintain their function after 23	  
secretion and assembly, conferring artificial functions to the biofilm as a whole 24	  
(89)(Figure 2B). Based on this work, Botyanszki et al (90) exploited the curli system of 25	  
	   16 
E. coli to create a biocatalytic biofilm in which a network of functional nanofibers are 1	  
capable of covalently and site-specifically immobilize an industrially relevant enzyme, 2	  
theα-amylase. 3	  
So far, curli has been the most engineered bacterial amyloid protein. However, 4	  
manipulation of others amyloid components present in biofilm matrices of different 5	  
bacteria might allow the fabrication of functionalized biofilms with different properties. 6	  
For example, taking advantage of the amyloid assembly properties of Bap, this protein 7	  
might serve as a potential biotechnological tool by fusing its N-terminal domain to 8	  
specific peptides tags. The key role of pH and Ca2+ in the formation of Bap assemblies 9	  
could be used to control the disruption or formation of programmed S. aureus biofilms 10	  
(Figure 2A). Because most biofilms in nature are composed by more than one species, it 11	  
would be interesting to study microbial consortia where multiple engineered 12	  
amyloidogenic proteins produced by different bacteria could work as a complex 13	  
nanomaterial to fulfill several technological applications.  14	  
 15	  
Concluding remarks 16	  
Functional amyloids are common structural components of the extracellular matrix in 17	  
bacterial biofilms. In regard to this function, the amyloid conformation provides at least 18	  
two major advantages compared to other protein mechanisms. Firstly, the assembly of 19	  
protein monomers into the amyloid insoluble aggregates implies a switch in protein 20	  
conformation that usually depends on specific environmental conditions. This simple 21	  
requirement broadens the biofilm regulatory network by providing an additional level of 22	  
control that enables biofilm development only under particular environmental 23	  
conditions. Secondly, the stability of the amyloid structure and its intrinsic resistance 24	  
against proteases prevents the destruction of the biofilm matrix scaffold in the presence 25	  
	   17 
of extracellular proteases. These two obvious advantages may explain why different 1	  
bacteria coincide in producing proteins with the capacity to form amyloid structures to 2	  
build the biofilm matrix. However, additional still unknown reasons could justify the 3	  
use of amyloid fibers as basic building blocks of the bacterial biofilm matrix. 4	  
Deepening our knowledge in the properties that amyloids provide to biofilm matrix will 5	  
be fundamental to understand the benefits of living in microbial communities embedded 6	  
in a self-produced extracellular matrix.  7	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Figure 1. Dedicated or simplistic amyloid-like fibers formation systems in gram-19	  
positive and gram-negative bacteria. A) Sec export system secretes the products of 20	  
tapA-sipW-tasA operon through the inner membrane (IM) of B. subtilis. SipW acts as a 21	  
signal peptidase cleaving the signal peptide from TasA and TapA. TapA allows the 22	  
anchorage of fibers to the cell wall (CW), and TasA is the major component of the 23	  
fibers. SinR represses the operon, but when conditions are propitious for biofilm 24	  
formation SinI antagonizes SinR. The C-terminus of SipW has also a regulatory effect 25	  
	   26 
on the operon. In S. aureus  αPSM, βPSMs and δ-toxin monomers are transported 1	  
outside the cell through an ATP-dependent ABC transporter (PmtB and PmtD 2	  
transmembrane proteins, linked to ATPases PmtA and PmtC). PSMs can be present as 3	  
soluble monomers, or, when required, forming amyloid-like fibers. Expression of α and 4	  
β psm genes is induced by AgrA, the response regulator of the Agr system. B) All Fap 5	  
and Csg proteins (except for CsgD) are expulsed via Sec across the inner membrane. In 6	  
the case of curli, the major fiber subunit CsgA and the nucleator CsgB are secreted 7	  
across the outer membrane (OM) through CsgG channel, and once on the cell surface 8	  
they start to polymerize into amyloidogenic fibers. Accesory proteins CsgC and CsgE 9	  
regulate export by CsgG, and CsgF assist the nucleation of CsgA. CsgD is the master 10	  
regulator of csgBAC operon. In Pseudomonas, Fap B, FapC and FapE are further 11	  
secreted across the outer membrane through FapF where FapB nucleates fiber assembly 12	  
of FapC and, in minor proportion, FapE. FapA likely control FapB and FapC secretion, 13	  
and FapD would act as a protease of Fap proteins. C) Once is anchored to the cell wall, 14	  
Bap of S. aureus is processed by proteases present in the medium, liberating the N-15	  
terminal fragments that will ultimately self-assemble into amyloid like fibrillar 16	  
structures upon acidification of the media and in the absence of calcium. In S. mutans, 17	  
non-attached P1 adhesin (AgI/II) would presumably form amyloidogenic fibers through 18	  
its  β-sheet rich V-region and C-terminal domain. D) The autotransporter Ag43 present 19	  
in E. coli, though not considered a real amyloid, represent a very simplistic model of 20	  
amyloid folding due to the high β-helix with β-strand conformation adopted by Ag43α 21	  
subunit at the bacterial envelope. 22	  
 23	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Figure 2. Development of functionalized amyloid-dependent biofilms in gram-12	  
negative and gram-positive bacteria. A) In E. coli, the major curli protein CsgA is 13	  
engineered by fusing variable tags at its C-terminus. Once in the extracellular media, the 14	  
fusion protein self-assembles into functional amyloid nanofibers. It is possible to obtain 15	  
multifunctional biofilms by expressing engineered CsgA proteins under the control of 16	  
different inducible promoters. The addition of measured concentrations of inducer 17	  
molecules grants the expression and production of curli fibers containing precise 18	  
multiple designed functions as a result of random extracellular self-assembly of CsgA 19	  
monomers. B) In the case of S. aureus, variable tags fused to the C-terminal part of B 20	  
domain of Bap could allow the formation of engineered Bap fibers. Since B domain of 21	  
Bap (amino acids 362 to 819) is sufficient to bestow multicellular behavior, it could be 22	  
possible to express engineered Bap_B proteins under the control of an inducible 23	  
promoter. The property of Bap to reversibly form amyloids according to pH and Ca2+ 24	  
	   28 
levels in the media could be used as an external way to control the formation or 1	  
disruption of functionalized biofilms.  2	  
  3	  
  4	  
	   29 
 1	  
Table 1. Summary of compounds showing suppressive effect on bacterial amyloids. 2	  
Amyloid 
inhibitors 
Anti-biofilm 
effect 
Bacterial 
amyloid target 
Eukaryotic 
amyloid target 
Reference 
FN075 
 
 
E. coli Curli 
Type-I pili 
 (75) 
Rifapentine 
 
E. coli Curli  (81) 
D-aminoacids 
 
 
 
B. subtilis 
S. aureus 
Pseudomonas 
TasA  (82) 
AA-861 
 
 
 
B. subtilis 
B. cereus 
E. coli 
TsaA 
 
Curli 
Yeast New1 (76) 
Parthenolide 
 
 
 
B. subtilis 
B. cereus 
E. coli 
TsaA 
 
Curli 
Yeast New1 (76) 
EGCG 
 
 
S. mutants 
S. aureus 
P1 adhesin 
Bap 
α-synuclein 
Amiloid-β 
(60) 
Taglialegna et al 
CsgC - Curli α-synuclein (80) 
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